<?xml version="1.0" encoding="utf-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Consolidated Gems, Inc.</title><link>https://investorshangout.com/Consolidated-Gems-Inc-CGEM-88471/</link><description><![CDATA[Consolidated Gems, Inc. (CGEM)]]></description><language>en-us</language><pubDate>Sat, 05 Sep 2026 05:17:17 GMT</pubDate><copyright>Copyright InvestorsHangout.com</copyright><atom:link href="https://investorshangout.com/Consolidated-Gems-Inc-CGEM-88471/" rel="self" type="application/rss+xml"/><item><title>whytestocks: $CGEM News Article - Cullinan Therapeutics Announces Appointment of Mary Kay Fenton as Chief Financi</title><link>https://investorshangout.com/post/view?id=6689188</link><guid>https://investorshangout.com/post/view?id=6689188</guid><description><![CDATA[whytestocks
]]></description><pubDate>Mon, 29 Apr 2024 17:05:55 GMT</pubDate></item><item><title>whytestocks: $CGEM News Article - Cullinan Oncology Inc. (NASDAQ: CGEM) Leading the Way in Friday Trading Based o</title><link>https://investorshangout.com/post/view?id=6688452</link><guid>https://investorshangout.com/post/view?id=6688452</guid><description><![CDATA[whytestocks
]]></description><pubDate>Fri, 26 Apr 2024 15:30:50 GMT</pubDate></item><item><title>whytestocks: $CGEM News Article - Why Is Cullinan Therapeutics Stock Trading Higher On Wednesday? | Benzinga </title><link>https://investorshangout.com/post/view?id=6687748</link><guid>https://investorshangout.com/post/view?id=6687748</guid><description><![CDATA[whytestocks
]]></description><pubDate>Wed, 24 Apr 2024 18:45:47 GMT</pubDate></item><item><title>whytestocks: $CGEM News Article - Cullinan Therapeutics to Present Clinical Data from Phase 1 Study Evaluating No</title><link>https://investorshangout.com/post/view?id=6687675</link><guid>https://investorshangout.com/post/view?id=6687675</guid><description><![CDATA[whytestocks
]]></description><pubDate>Wed, 24 Apr 2024 16:30:57 GMT</pubDate></item><item><title>whytestocks: $CGEM News Article - Cullinan Therapeutics to Present Clinical Data from Phase 1 Study Evaluating No</title><link>https://investorshangout.com/post/view?id=6687662</link><guid>https://investorshangout.com/post/view?id=6687662</guid><description><![CDATA[whytestocks
]]></description><pubDate>Wed, 24 Apr 2024 16:10:50 GMT</pubDate></item><item><title>whytestocks: $CGEM News Article - Cullinan Shifts Focus From Oncology To Autoimmune Disorders, Raises $280M Via E</title><link>https://investorshangout.com/post/view?id=6685240</link><guid>https://investorshangout.com/post/view?id=6685240</guid><description><![CDATA[whytestocks
]]></description><pubDate>Tue, 16 Apr 2024 17:55:46 GMT</pubDate></item><item><title>whytestocks: $CGEM News Article - Cullinan Management Inc. (NASDAQ: CGEM) Records 52-Week High Tuesday Morning </title><link>https://investorshangout.com/post/view?id=6685158</link><guid>https://investorshangout.com/post/view?id=6685158</guid><description><![CDATA[whytestocks
]]></description><pubDate>Tue, 16 Apr 2024 15:00:46 GMT</pubDate></item><item><title>whytestocks: $CGEM News Article - Cullinan Therapeutics Announces Strategic Expansion into Autoimmune Diseases | </title><link>https://investorshangout.com/post/view?id=6685154</link><guid>https://investorshangout.com/post/view?id=6685154</guid><description><![CDATA[whytestocks
]]></description><pubDate>Tue, 16 Apr 2024 14:50:46 GMT</pubDate></item><item><title>whytestocks: $CGEM News Article - Cullinan Therapeutics Announces Strategic Expansion into Autoimmune Diseases </title><link>https://investorshangout.com/post/view?id=6685151</link><guid>https://investorshangout.com/post/view?id=6685151</guid><description><![CDATA[whytestocks
]]></description><pubDate>Tue, 16 Apr 2024 14:35:49 GMT</pubDate></item><item><title>whytestocks: $CGEM News Article - Cullinan Oncology and Taiho Pharmaceutical Complete Agreement for Strategic Col</title><link>https://investorshangout.com/post/view?id=6426906</link><guid>https://investorshangout.com/post/view?id=6426906</guid><description><![CDATA[whytestocks
]]></description><pubDate>Thu, 23 Jun 2022 19:41:00 GMT</pubDate></item><item><title>whytestocks: $CGEM News Article - Cullinan Oncology to Participate in Upcoming Virtual Healthcare Conferences </title><link>https://investorshangout.com/post/view?id=6377371</link><guid>https://investorshangout.com/post/view?id=6377371</guid><description><![CDATA[whytestocks
]]></description><pubDate>Tue, 05 Apr 2022 12:11:01 GMT</pubDate></item><item><title>whytestocks: $CGEM News Article - Cullinan Oncology to Present at the Barclays Global Healthcare Conference </title><link>https://investorshangout.com/post/view?id=6359418</link><guid>https://investorshangout.com/post/view?id=6359418</guid><description><![CDATA[whytestocks
]]></description><pubDate>Wed, 09 Mar 2022 21:11:19 GMT</pubDate></item><item><title>whytestocks: $CGEM News Article - Cullinan Oncology Provides Corporate Update and Reports Second Quarter 2021 Fin</title><link>https://investorshangout.com/post/view?id=6210965</link><guid>https://investorshangout.com/post/view?id=6210965</guid><description><![CDATA[whytestocks
]]></description><pubDate>Tue, 10 Aug 2021 18:05:48 GMT</pubDate></item><item><title>whytestocks: $CGEM News Article - Cullinan Oncology Announces Phase 1/2a Interim Data For Cullinan Pearl&#039;s CLN-08</title><link>https://investorshangout.com/post/view?id=6152211</link><guid>https://investorshangout.com/post/view?id=6152211</guid><description><![CDATA[whytestocks
]]></description><pubDate>Fri, 04 Jun 2021 14:05:46 GMT</pubDate></item><item><title>chartguy89: CGEM 0.03 Stock Charts $CGEM 1 Month Chart </title><link>https://investorshangout.com/post/view?id=1290632</link><guid>https://investorshangout.com/post/view?id=1290632</guid><description><![CDATA[chartguy89
]]></description><pubDate>Thu, 06 Mar 2014 14:37:35 GMT</pubDate></item></channel></rss>